Tevogen
@tevogen.com
Tevogen Bio is a late-stage biotech company harnessing the power of cytotoxic T lymphocytes (CTLs) with its ExacTcell platform. This pioneering technology produces scalable, rapidly available, unmodified allogeneic CTLs for the treatment of cancers, viral infections and the prevention of long-term complications of these conditions.
Tevogen's Company Logos
Tevogen's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#4C4B4C
Emperor
76, 75, 76
300, 1, 30
0, 1, 0, 70
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#27626E
Casal
39, 98, 110
190, 48, 29
65, 11, 0, 57
About Tevogen
Tevogen Bio is a pioneering brand driven by distinguished scientists and experienced biopharmaceutical leaders. With a focus on personalized immunotherapies, they have successfully developed and commercialized multiple franchises, pushing the boundaries of medical innovation. Tevogen Bio works in collaboration with strategic partners to accelerate the development of their lead product, moving from discovery to clinical phase within an impressive 18 months.
This rapid progress shaves years off the industry's standard for drug development timelines. By leveraging their proprietary technology, Tevogen Bio overcomes traditional barriers to targeted T cell therapies, enhancing speed to patient and product purity. They are committed to making personalized immunotherapies accessible to all, revolutionizing the healthcare industry.
With a team of experts and disruptive business models, Tevogen Bio is at the forefront of cutting-edge medical advancements
Company type
Privately Held
Year founded
2020
Company size
501-1000 employees
Related Brands
Tags
Clinical-stage immunotherapy
Off-the-shelf t cell therapy
CD8+ cytotoxic T lymphocytes
HLA-targeted T cell receptors
Cell therapy manufacturing
